Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSynthomer Regulatory News (SYNT)

Share Price Information for Synthomer (SYNT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 271.00
Bid: 268.00
Ask: 271.00
Change: -5.50 (-1.99%)
Spread: 3.00 (1.119%)
Open: 272.00
High: 276.00
Low: 267.50
Prev. Close: 276.50
SYNT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Interim Management Statement

7 Nov 2013 07:00

RNS Number : 3806S
Synthomer PLC
07 November 2013
 



7th November 2013

 

SYNTHOMER PLC

 

INTERIM MANAGEMENT STATEMENT

 

Synthomer plc ("Synthomer" or "the Group") today issues its interim management statement for the period 1 July to 6 November 2013.

 

Trading

 

The Group has performed broadly in line with the Board's expectations since the last update provided at the interim results in August.

 

Trading conditions in Europe have remained challenging, particularly in construction related areas, resulting in Europe and North America (ENA) operating profit being slightly below the same period last year. Whilst volumes showed some improvement over the prior year, the softer margins we saw in the first half persisted. In a difficult demand environment, a number of pricing actions have been taken.

 

In Asia and ROW, trading has remained strong. The solid demand for nitrile products seen during the first half of the year continued throughout the period reflecting the ongoing benefits of new product launches at the beginning of the year.

 

The Group's financial position remains robust with net debt at the period end slightly lower than the level reported at the interim results. As we approach the end of the year, we expect the seasonal working capital profile of the business to ease, further improving our net debt position.

 

Outlook

 

In Europe, where we have seen no material improvement in market conditions to date, we continue to expect second half operating profit to be lower than the first half of the year. This will reflect the impact of normal seasonal factors and is expected to deliver ENA profitability slightly below that achieved in the second half of the prior year. The Board continues to expect Asia and ROW operating profit in the second half to be in line with the first half, substantially ahead of the prior year.

 

Commenting Adrian Whitfield, Chief Executive Officer, said:

 

"Whilst challenging market conditions in Europe have persisted, our business has held up well and strong cash generation is enabling us to maintain investment in emerging market growth. The nitrile business in Asia has continued its solid performance and we are encouraged by the demand growth in the region."

 

Enquiries:

 

Adrian Whitfield, Chief Executive Officer

Charles Armitstead / Rosie Oddy

David Blackwood, Chief Financial Officer

Pendomer Communications

Tel: 01279 442791

Tel: 020 3603 5220

 

The company will host a conference call for analysts at 8.30am today. Please contact Pendomer Communications on 020 3603 5220 for dial in details.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSUNSSROAAARAA
Date   Source Headline
7th Jun 20124:35 pmRNSDirector/PDMR Shareholding
25th May 201211:00 amRNSDirector Declaration
17th May 201212:22 pmRNSResult of AGM
17th May 201211:00 amRNSDirectorate Change
17th May 20127:00 amRNSInterim Management Statement
14th May 20123:47 pmRNSAnnual Information Update
17th Apr 20129:18 amRNSAnnual Financial Report
3rd Apr 20123:11 pmRNSDirector/PDMR Shareholding
2nd Apr 20127:00 amRNSMarl Site Operations
28th Mar 20125:15 pmRNSHolding(s) in Company
26th Mar 20127:00 amRNSDirector/PDMR Shareholding
23rd Mar 20127:00 amRNSDirectorate Change
19th Mar 20124:10 pmRNSDirector/PDMR Shareholding
16th Mar 20121:48 pmRNSDirector/PDMR Shareholding
16th Mar 20121:46 pmRNSDirector/PDMR Shareholding
16th Mar 20121:09 pmRNSDirector/PDMR Shareholding
14th Mar 20123:52 pmRNSDirector/PDMR Shareholding
14th Mar 20127:00 amRNSFinal Results
11th Jan 20127:00 amRNSTrading Update
9th Jan 201210:24 amRNSDirector/PDMR Shareholding
3rd Jan 20124:51 pmRNSDirector/PDMR Shareholding
1st Dec 20117:00 amRNSDisposal of Pharma Division
25th Nov 20117:00 amRNSDirectorate Change
10th Nov 20117:00 amRNSInterim Management Statement
1st Nov 20113:33 pmRNSHolding(s) in Company
31st Oct 201110:15 amRNSHolding(s) in Company
20th Oct 20112:42 pmRNSHolding(s) in Company
17th Oct 20118:20 amRNSAcquisition
28th Sep 20117:00 amRNSAnalyst and Investor Site Visit
5th Sep 20117:00 amRNSAppointment of Joint Broker
26th Aug 20117:00 amRNSHalf Yearly Report
10th Aug 20118:58 amRNSHolding(s) in Company
4th Aug 20119:02 amRNSBoard appointment
27th Jul 20111:12 pmRNSHolding(s) in Company
29th Jun 20114:46 pmRNSDirector/PDMR Shareholding
29th Jun 20114:44 pmRNSDirector/PDMR Shareholding
29th Jun 20112:17 pmRNSResult of EGM
22nd Jun 20113:59 pmRNSHolding(s) in Company
16th Jun 20114:39 pmRNSHolding(s) in Company
16th Jun 20114:37 pmRNSHolding(s) in Company
13th Jun 201111:14 amRNSNotice of EGM
9th Jun 201110:44 amRNSHolding(s) in Company
12th May 20113:51 pmRNSResult of AGM
12th May 20117:00 amRNSInterim Management Statement
4th May 20113:17 pmRNSAnnual Information Update
3rd May 20111:30 pmRNSHolding(s) in Company
28th Apr 201112:28 pmRNSHolding(s) in Company
21st Apr 20113:24 pmRNSDirector/PDMR Shareholding
21st Apr 20113:19 pmRNSDirector/PDMR Shareholding
7th Apr 20113:00 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.